Table 3.

Time taken to complete the sample phase and total exploration levels in sample and test phases in the novel object preference test (5 min and 2 h delays)

Lesion	5 min delay				2 h delay
	Time taken to complete sample phase (s)	Expl. in sample phase (s)	Expl. in test phase (first min) (s)	Expl. in test phase (first 2 min) (s)	Time taken to complete sample phase (s)	Expl. in sample phase (s)	Expl. in test phase (first min) (s)	Expl. in test phase (first 2 min) (s)
SHAM	225 ± 8.0	33.1 ± 1.2	11.0 ± 0.9	17.3 ± 1.3	240 ± 0	29.1 ± 1.2	7.9 ± 0.7	11.7 ± 0.7
PRH–mPFC CONTRA	228 ± 9.2	33.6 ± 1.9	13.4 ± 1.0	17.3 ± 1.2	231 ± 8.3	27.2 ± 2.2	8.5 ± 1.0	12.3 ± 0.9
PRH–mPFC IPSI	226 ± 9.6	35.7 ± 1.5	12.3 ± 2.2	16.9 ± 2.7	239 ± 1.0	29.1 ± 2.2	6.0 ± 0.8	11.9 ± 1.3
mPFC	233 ± 4.1	37.3 ± 4.1	9.1 ± 1.2	13.9 ± 1.7	240 ± 0	28.0 ± 3.2	7.8 ± 1.1	12.3 ± 1.6
PRH	240 ± 0	29.3 ± 2.0	7.05 ± 0.9	12.3 ± 1.5	240 ± 0	25.3 ± 1.7	7.2 ± 1.0	11.3 ± 1.6

Expl., Exploration.